Lord Abbett Health Care Fund Class R5 (LHCTX)
NASDAQ · Mutual Fund · Delayed Price · Currency is USD
21.01
-0.25 (-1.18%)
At close: Apr 29, 2026

LHCTX Holdings Information

LHCTX is a mutual fund with a total of 59 individual holdings. The top holdings are Eli Lilly and Company stock at 9.58%, Gilead Sciences at 4.63%, AstraZeneca at 4.54%, argenx SE at 3.71%, and Tarsus Pharmaceuticals at 3.21%.

Total Holdings
59
Top 10 Percentage
39.50%
Asset Class
Equity
Fund Category
Health
Assets
8.17M
Forward PE Ratio
25.56

Breakdown by Sector

Top 25 Holdings

No.SymbolName WeightShares
1LLYEli Lilly and Company9.58%775
2GILDGilead Sciences, Inc.4.63%2,647
3LON: AZNAstraZeneca PLC4.54%1,846
4EBR: ARGXargenx SE3.71%406
5TARSTarsus Pharmaceuticals, Inc.3.21%3,622
6CORCencora, Inc.2.98%681
7NTRANatera, Inc.2.81%1,151
8GHGuardant Health, Inc.2.71%2,459
9ISRGIntuitive Surgical, Inc.2.70%457
10TMOThermo Fisher Scientific Inc.2.62%428
11TERNTerns Pharmaceuticals, Inc.2.52%5,083
12NKTRNektar Therapeutics2.46%3,038
13JNJJohnson & Johnson2.34%802
14COGTCogent Biosciences, Inc.2.27%4,983
15CVSCVS Health Corporation2.18%2,320
16SWX: NOVNNovartis AG2.16%1,082
17EPA: ELEssilorLuxottica Société anonyme2.13%681
18ASNDAscendis Pharma A/S1.91%698
19ABVXABIVAX Société Anonyme1.85%1,296
20EBR: UCBUCB SA1.83%522
21SWX: GALDGalderma Group AG1.82%818
22MIRMMirum Pharmaceuticals, Inc.1.79%1,651
23BBIOBridgeBio Pharma, Inc.1.78%2,278
24MDGLMadrigal Pharmaceuticals, Inc.1.78%350
25VRTXVertex Pharmaceuticals Incorporated1.57%269
Showing 25 of 59 holdings
Subscribe to see the full list
As of Feb 28, 2026